Related Experiment Video
Updated: Aug 11, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
[Does the Roux-en-Y-stasis syndrome still exist?]
Luca Cozzaglio1, Massimiliano Coladonato, Celestino Tito Dagrada
1Unità Operativa di Chirurgia Generale, Istituto Clinico Humanitas, Rozzano, Milano.
Chirurgia Italiana
|April 19, 2005
Summary
Roux-en-Y-stasis syndrome (RYS) is a rare complication after subtotal gastrectomy. Prompt diagnosis and tailored therapy based on the specific cause are crucial for effective management of this condition.
Area of Science:
- Gastroenterology
- Surgical Complications
- Oncology
Background:
- Roux-en-Y-stasis syndrome (RYS) is a known complication following subtotal gastrectomy.
- It is characterized by delayed gastric emptying and vomiting, impacting patient recovery.
- Understanding the frequency and causes of RYS is essential for surgical practice.
Observation:
- The study reviewed 147 distal gastrectomies performed between November 1996 and June 2004.
- Five cases of RYS were identified, with patients having a mean age of 78 years.
- The underlying causes of RYS varied, including functional issues, duodenal fistula, anastomotic stenosis, and jejunal obstruction.
Findings:
- RYS occurred in 5 out of 147 patients (3.4%) undergoing distal gastrectomy.
- Functional causes and edematous stenosis were managed with medical therapy.
- Jejunal obstruction due to adhesions necessitated reoperation in two patients.
Implications:
- Roux-en-Y-stasis syndrome is an infrequent but significant complication of subtotal gastrectomy.
- Accurate diagnosis of the RYS cause is paramount for selecting the most effective treatment strategy.
- This highlights the need for careful patient monitoring and individualized therapeutic approaches post-gastrectomy.
More Related Videos
Related Concept Videos
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
01:25Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...